New Melanoma Stories
13 June 2013 In Melanoma Stories
Melanoma has touched the lives of many people, and MRA is always eager to hear melanoma stories from patients, researchers, family members, and everyone else affected by this disease. We've recently added two more must-read survivor stories to the MRA website, and here's a preview:
Two MRA-Sponsored Investigators Published Papers in the New England Journal of Medicine
12 June 2013 In News
Two MRA-sponsored investigators recently reported on the clinical testing of immune checkpoint inhibitors targeting a pathway known as PD-1 in the New England Journal of Medicine. This therapeutic approach, whose clinical utility was established by the FDA approval of ipilimumab in 2011, has produced promising data in patients with advanced melanoma.
Melanoma News Round-Up June 7, 2013
7 June 2013 In News
Promising New Cancer Drugs Empower the Body's Own Immune System via the New York Times MSK Researchers Report Major Advances in Treatment for Metastatic Eye and Skin Melanoma via Memorial Sloan Kettering Meet the New Class of Drugs Being Deployed in the the Struggle Against Cancer: Checkpoint Blockade via the Economist For a...
New Melanoma Therapies Approved
31 May 2013 In News
[caption id="attachment_200" align="aligncenter" width="576"] © Ladyminnie | Dreamstime Stock Photos & Stock Free Images[/caption] These are the best types of posts to write: On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine...
Safe Sun Style: Guest Post from Meg of SPF Love
30 May 2013 In Allies & Partnerships
It's a common misconception that sun safety is not fashion-forward. Our guest blogger and May ally SPF Love begs to differ. [caption id="attachment_203" align="aligncenter" width="300"] Meg of SPF Love[/caption] I'm honored to be guest blogging for MRA. I started my journey over a year ago when I decided to start...
Wendy Selig Explains MRA's Focus on Collaboration
29 May 2013 In Allies & Partnerships
Listen to Wendy explain MRA's singular focus on collaboration and its transformative effect on awareness building and the drug development process! [youtube url=http://www.youtube.com/watch?v=NNYHqxtchlQ] This in an excerpt from a longer interview with m/Oppenheim Associates, an executive search firm that specializes in recruiting non-profit leaders. You can watch the full interview here.
MRA CSO Louise Perkins Interviewed at BIO International Convention
20 May 2013 In Events
MRA recently attended the BIO International Convention, the biopharma industry's largest gathering of drug development professionals and decision-makers. We exhibited and held meetings in the Advocacy Pavilion, and our CSO was featured in the BIO Buzz Center, where she and Lauren Neff, BIO's Director of Alliance Development, discussed MRA's mission and...
MRA & Leveraged Finance Fights Melanoma Video Series
19 May 2013 In Events
[brightcove vid=2372187009001&exp3=1405557362001&surl=http://c.brightcove.com/services&pubid=1405556719001&pk=AQ~~,AAABR0G1fZk~,HNsXz5NC104V7oLZ6aVapLmHmSUC2yKF&w=480&h=270] MRA is holding its 2nd annual Leveraged Finance Fights Melanoma event next week in NYC. Our friends at Privcap produced a series of videos featuring people from the leveraged finance community who have been touched by melanoma.
We are delighted to be launching the Melanoma Research Alliance (MRA) blog – welcome! We felt the name Melanoma Focus had important significance because MRA is singularly focused on defeating melanoma and moving toward a day when no one suffers or dies from this deadly cancer. And we know how...
Adjuvant Therapy Advocacy ASCO Awareness Biopharma Board Members BRAF Cancer Combination Therapy Detection FDA Francis Collins Grants Health HHS Immunotherapy Louise Perkins Melanoma microbiome MRA News Nonprofits Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Redheads Research Science Social Media Surgeon General Surgeon General's Call to Action to Prevent Skin Cancer Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People